Información del producto
LX7101 is a potent, selective, and orally bioavailable tyrosine kinase inhibitor. It inhibits the proliferation of endothelial cells (ECs) in vitro and the growth of EC-derived tumors in vivo. In both cell culture and animal models, LX7101 potently inhibits phosphodiesterase type-5 (PDE5), which is an enzyme that catalyzes the hydrolysis of cyclic guanosine monophosphate (cGMP). Inhibition of PDE5 leads to increased cGMP levels and has been shown to have therapeutic potential for the treatment of erectile dysfunction. LX7101 also blocks tyrosine kinases, which are enzymes that transmit signals from outside the cell to inside the cell. It has been shown to inhibit nerve injury in rats with peripheral nerve injury. The safety profile of LX7101 has been evaluated by toxicological studies in Sprague-Dawley rats and by clinical development in patients with cancer or cavernosal
Propiedades químicas
Consulta técnica sobre: 3D-SXB18969 LX7101
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
